Cargando…

The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial

BACKGROUND: In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of perpetrator programmes for reduction of abuse is uncertain. This study aims to estimate the effectiveness and cost-effectiveness of a perpetrator programme for...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Karen, Man, Mei-See, Bloomer, Rachael, Cochrane, Madeleine, Cole, Melissa, Dheensa, Sandi, Eisenstadt, Nathan, Feder, Gene, Gaunt, Daisy M., Leach, Rwth, Kandiyali, Rebecca, Noble, Sian, Peters, Tim J., Shirkey, Beverly A., Cramer, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540403/
https://www.ncbi.nlm.nih.gov/pubmed/37770906
http://dx.doi.org/10.1186/s13063-023-07612-6
_version_ 1785113709503315968
author Morgan, Karen
Man, Mei-See
Bloomer, Rachael
Cochrane, Madeleine
Cole, Melissa
Dheensa, Sandi
Eisenstadt, Nathan
Feder, Gene
Gaunt, Daisy M.
Leach, Rwth
Kandiyali, Rebecca
Noble, Sian
Peters, Tim J.
Shirkey, Beverly A.
Cramer, Helen
author_facet Morgan, Karen
Man, Mei-See
Bloomer, Rachael
Cochrane, Madeleine
Cole, Melissa
Dheensa, Sandi
Eisenstadt, Nathan
Feder, Gene
Gaunt, Daisy M.
Leach, Rwth
Kandiyali, Rebecca
Noble, Sian
Peters, Tim J.
Shirkey, Beverly A.
Cramer, Helen
author_sort Morgan, Karen
collection PubMed
description BACKGROUND: In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of perpetrator programmes for reduction of abuse is uncertain. This study aims to estimate the effectiveness and cost-effectiveness of a perpetrator programme for men. METHODS: Pragmatic two-group individually randomised controlled trial (RCT) with embedded process and economic evaluation. Five centres in southwest England and South Wales aim to recruit 316 (reduced from original target of 366) male domestic abuse perpetrators. These will be randomised 2:1 to a community-based domestic abuse perpetrator programme (DAPP) or usual care comparator with 12-month follow-up. Female partners/ex-partners will be invited to join the study. The intervention for men comprises 23 weekly sessions of a group programme delivered in voluntary sector domestic abuse services. The intervention for female partners/ex-partners is one-to-one support from a safety worker. Men allocated to usual care receive no intervention; however, they are free to access other services. Their partners/ex-partners will be signposted to support services. Data is collected at baseline, and 4, 8 and 12 months’ follow-up. The primary outcome is men’s self-reported abusive behaviour measured by the Abusive Behaviour Inventory (ABI-29) at 12 months. Secondary measures include physical and mental health status and resource use alongside the abuse measure ABI (ABI-R) for partners/ex-partners and criminal justice contact for men. A mixed methods process evaluation and qualitative study will explore mechanisms of effectiveness, judge fidelity to the intervention model using interviews and group observations. The economic evaluation, over a 1-year time horizon from three perspectives (health and social care, public sector and society), will employ a cost-consequences framework reporting costs alongside economic outcomes (Quality-Adjusted Life Years derived from EQ-5D-5L, SF-12 and CHU-9D, and ICECAP-A) as well as the primary and other secondary outcomes. DISCUSSION: This trial will provide evidence of the (cost)effectiveness of a DAPP. The embedded process evaluation will further insights in the experiences and contexts of participants and their journey through a perpetrator programme, and the study will seek to address the omission in other studies of economic evaluations. TRIAL REGISTRATION: ISRCTN15804282, April 1, 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07612-6.
format Online
Article
Text
id pubmed-10540403
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105404032023-09-30 The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial Morgan, Karen Man, Mei-See Bloomer, Rachael Cochrane, Madeleine Cole, Melissa Dheensa, Sandi Eisenstadt, Nathan Feder, Gene Gaunt, Daisy M. Leach, Rwth Kandiyali, Rebecca Noble, Sian Peters, Tim J. Shirkey, Beverly A. Cramer, Helen Trials Study Protocol BACKGROUND: In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of perpetrator programmes for reduction of abuse is uncertain. This study aims to estimate the effectiveness and cost-effectiveness of a perpetrator programme for men. METHODS: Pragmatic two-group individually randomised controlled trial (RCT) with embedded process and economic evaluation. Five centres in southwest England and South Wales aim to recruit 316 (reduced from original target of 366) male domestic abuse perpetrators. These will be randomised 2:1 to a community-based domestic abuse perpetrator programme (DAPP) or usual care comparator with 12-month follow-up. Female partners/ex-partners will be invited to join the study. The intervention for men comprises 23 weekly sessions of a group programme delivered in voluntary sector domestic abuse services. The intervention for female partners/ex-partners is one-to-one support from a safety worker. Men allocated to usual care receive no intervention; however, they are free to access other services. Their partners/ex-partners will be signposted to support services. Data is collected at baseline, and 4, 8 and 12 months’ follow-up. The primary outcome is men’s self-reported abusive behaviour measured by the Abusive Behaviour Inventory (ABI-29) at 12 months. Secondary measures include physical and mental health status and resource use alongside the abuse measure ABI (ABI-R) for partners/ex-partners and criminal justice contact for men. A mixed methods process evaluation and qualitative study will explore mechanisms of effectiveness, judge fidelity to the intervention model using interviews and group observations. The economic evaluation, over a 1-year time horizon from three perspectives (health and social care, public sector and society), will employ a cost-consequences framework reporting costs alongside economic outcomes (Quality-Adjusted Life Years derived from EQ-5D-5L, SF-12 and CHU-9D, and ICECAP-A) as well as the primary and other secondary outcomes. DISCUSSION: This trial will provide evidence of the (cost)effectiveness of a DAPP. The embedded process evaluation will further insights in the experiences and contexts of participants and their journey through a perpetrator programme, and the study will seek to address the omission in other studies of economic evaluations. TRIAL REGISTRATION: ISRCTN15804282, April 1, 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07612-6. BioMed Central 2023-09-28 /pmc/articles/PMC10540403/ /pubmed/37770906 http://dx.doi.org/10.1186/s13063-023-07612-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Morgan, Karen
Man, Mei-See
Bloomer, Rachael
Cochrane, Madeleine
Cole, Melissa
Dheensa, Sandi
Eisenstadt, Nathan
Feder, Gene
Gaunt, Daisy M.
Leach, Rwth
Kandiyali, Rebecca
Noble, Sian
Peters, Tim J.
Shirkey, Beverly A.
Cramer, Helen
The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
title The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
title_full The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
title_fullStr The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
title_full_unstemmed The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
title_short The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
title_sort effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540403/
https://www.ncbi.nlm.nih.gov/pubmed/37770906
http://dx.doi.org/10.1186/s13063-023-07612-6
work_keys_str_mv AT morgankaren theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT manmeisee theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT bloomerrachael theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT cochranemadeleine theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT colemelissa theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT dheensasandi theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT eisenstadtnathan theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT federgene theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT gauntdaisym theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT leachrwth theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT kandiyalirebecca theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT noblesian theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT peterstimj theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT shirkeybeverlya theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT cramerhelen theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT morgankaren effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT manmeisee effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT bloomerrachael effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT cochranemadeleine effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT colemelissa effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT dheensasandi effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT eisenstadtnathan effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT federgene effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT gauntdaisym effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT leachrwth effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT kandiyalirebecca effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT noblesian effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT peterstimj effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT shirkeybeverlya effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial
AT cramerhelen effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial